NuCana plc (NCNA)
After hours:
| Previous close | 0.8897 |
| Open | 0.9100 |
| Bid | 0.0000 x 1000 |
| Ask | 0.0000 x 900 |
| Day's range | 0.9000 - 0.9989 |
| 52-week range | 0.5170 - 2.2400 |
| Volume | |
| Avg. volume | 158,134 |
| Market cap | 51.674M |
| Beta (5Y monthly) | 1.34 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.1190 |
| Earnings date | 25 Apr 2023 - 01 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.75 |
- Globe Newswire
Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid
Ruling Has No Impact on NuCana’s Anti-Cancer ProTide PatentsMUNICH, Germany, March 24, 2023 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that, following a hearing on March 24, 2023, the Technical Board of Appeal (the “TBA”) of the European Patent Office (the “EPO”) issued an oral judgement that NuCana’s European Patent 2955190 (the “’190 patent”) is not valid. The TBA reversed the previous decisions of the EPO’s Examination Division which issued NuCana’s ‘190 patent and of the EPO’s O
- Simply Wall St.
We're Keeping An Eye On NuCana's (NASDAQ:NCNA) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
- Globe Newswire
NuCana to Participate in Two Upcoming Investor Conferences
EDINBURGH, United Kingdom, Feb. 28, 2023 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will participate in two upcoming investor conferences. Event: Cowen’s 43rd Annual Healthcare Conference Presentation Date: Tuesday, March 7, 2023Presentation Time: 10:30 AM ET Event: Oppenheimer's 33rd Annual Healthcare Conference Presentation Date: Tuesday, March 14, 2023Presentation Time: 12:40 PM ET The pres
